Paper Details

  1. Home
  2. Paper Details

Maintenance treatment of schizophrenia with risperidone or haloperidol: 2-year outcomes.

Author: BlairKaren E, GlynnShirley M, LibermanRobert P, MarderStephen R, MintzJim, RossDoreen, WidmarkClifford, WirshingDonna A, WirshingWilliam C

Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Research Support, U.S. Gov't, Non-P.H.S.Research funding provided by US government agencies other than the Public Health Service.

Overview

The study compared symptom outcomes, side effects, and social adjustment in stable schizophrenia outpatients who received 2 years of maintenance treatment with risperidone or haloperidol.
Paper Details　
Original Abstract of the Article :
Most controlled studies comparing second-generation and conventional antipsychotics have focused on the acute treatment of schizophrenia. The authors compared symptom outcomes, side effects, and social adjustment in stable schizophrenia outpatients who received 2 years of maintenance treatment with ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1176/appi.ajp.160.8.1405

データ提供：米国国立医学図書館（NLM）

Comparing Risperidone and Haloperidol for Schizophrenia Maintenance

This research delves into the fascinating world of schizophrenia treatment. It's like exploring a vast desert, where each treatment option is a different oasis. The researchers in this study used a controlled approach to compare the effectiveness of two common medications, risperidone and haloperidol, for maintaining a stable state in patients with schizophrenia. They meticulously examined symptom outcomes, side effects, and social adjustment over a period of two years. Their findings provide valuable insights into the long-term effects of these medications, guiding clinicians in making informed decisions for their patients.

Understanding the Long-Term Effects of Antipsychotics

The study revealed that both risperidone and haloperidol were effective in managing symptoms of schizophrenia over an extended period. However, there were subtle differences in their impact on various aspects of the patient's well-being. This highlights the importance of considering the individual needs of each patient when selecting the most appropriate treatment. Such insights are crucial for improving the lives of individuals living with schizophrenia.

Making Informed Choices for Schizophrenia Treatment

This research emphasizes the importance of carefully considering the long-term effects of antipsychotic medications. It's like choosing the right path through a desert – each medication can lead to different destinations, some with more benefits than others. Understanding the nuances of each treatment can lead to better outcomes for patients.

Dr.Camel's Conclusion

This research provides a valuable roadmap for navigating the complex landscape of schizophrenia treatment. By comparing the long-term effects of risperidone and haloperidol, this study sheds light on the importance of personalized care in managing this chronic condition. It reminds us that there is no one-size-fits-all approach to treatment, and each patient's journey requires careful consideration and a tailored approach.

Date :
  1. Date Completed 2003-09-05
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

12900301

DOI: Digital Object Identifier

10.1176/appi.ajp.160.8.1405

Related Literature

Article Analysis
・Effective treatment of schizophrenia
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.